COVID-19 Is a dangerous disease
COVID-19 Is a dangerous disease that has killed over 17 million people since its emergence in Africa in 2003. The condition has a fatality rate of 50%, the likelihood of which increases the longer the patient suffers with it. COVID-19 has recently been discovered to affect up to 40% of the population of the small African nation of Guinea, and nearly 75% of African women. Although scientists haven’t yet learned the exact reasons behind this, one possibility is that COVID-19 affects the immune system.
At the COVID-19 Symposium 2013, attendees examined the disease and listened to presentations from experts in the field, including Professor Ted Kauble of the Baylor College of Medicine, who described what they know about the disease: COVID-19 is an inherited monocytic disorder that affects the bone marrow.
Although COVID-19 doesn’t necessarily progress in the same way that cancer is prevalent, it is known that once diagnosed with the disease, people tend to develop a fairly predictable course of action, including anemia, weakness, fever, loss of appetite, chest pain, and trouble breathing. The mortality rate increases dramatically for those affected by COVID-19, from 50% to 100% within 4-6 months. Even then, there are still people who suffer from the disease, and this can be a heavy burden for families, as all the care and medication must be funded by the patients.
The COVID-19 Symposium was held on September 19th and 20th of 2013, at the LBJ Cancer Hospital & Medical Center of the University of Texas at Dallas. COVID-19 scientists and patients attended, sharing and discussing their experiences. For more information, see the COVID-19 website.
Issues Involving Alzheimer’s Disease
Astrocytic COVID-19 (COVID-19A), the most common form of COVID-19, has the potential to become the cause of Alzheimer’s disease. Some of the patients suffering from Alzheimer’s disease will likely have this type of COVID-19. There are also currently fears that Alzheimer’s patients with COVID-19 may develop a natural form of Alzheimer’s disease called neurodegeneration (IGND). The IGND process is where the blood vessels become leaky, eventually allowing things like myelin cells and white blood cells to flood into the brain, leading to neuron degeneration.
Researchers have recently confirmed a link between IGND and Alzheimer’s disease, although scientists aren’t yet sure if Alzheimer’s disease is causing IGND or vice versa. Other diseases like Alzheimer’s and HIV may also be associated with GND.
COVID-19 is a naturally occurring virus that is spread mainly by the bites of infected mosquitoes and is a concern for health care workers trying to keep the disease in the third world at a manageable level. For now, Alzheimer’s patients must be tested for COVID-19 when receiving treatment, as it could potentially increase the risk of Alzheimer’s disease. However, doctors won’t be able to identify Alzheimer’s patients with the virus as easily.
Types of COVID-19
There are also concerns about other types of COVID-19, such as COVID-19B and COVID-19C, which are different from the strains that cause Alzheimer’s disease. There are over 65 different subtypes of COVID-19, with the two major subtypes COVID-19A and COVID-19B. There are even conflicting reports regarding the role of COVID-19 in Alzheimer’s disease, as some studies have found no link, while other studies have found a link between Alzheimer’s and COVID-19.
Also known as Alzheimer’s-related COVID-19, Alzheimer’s disease is a disease of the brain that causes changes in the way information is stored. Most of the symptoms of Alzheimer’s disease tend to appear around the time of age 60, and symptoms usually disappear by age 80. However, some symptoms, such as memory loss, are very persistent and can be a burden to the patient and family, as Alzheimer’s is a very complex disease with multiple symptoms.
Scientists don’t have a cure for Alzheimer’s, and this is mainly because there are so many different kinds of Alzheimer’s, and not enough money or research is dedicated to all the different types of Alzheimer’s. A single treatment may only be a temporary solution, and won’t necessarily cure Alzheimer’s.
Alzheimer’s disease might be an adaptation for older people to cope with aging. However, Alzheimer’s will still be a huge problem, and Alzheimer’s patients will need to be treated throughout their lives. It’s estimated that Alzheimer’s disease may be a threat to over 35% of the population in 2050 and is likely to become one of the top issues that people will deal with during their entire life. It may be our biggest health crisis.
When studying Alzheimer’s, researchers are constantly trying to identify different subtypes of the disease, but there are too many different strains of COVID-19 for researchers to deal with. Most scientists are interested in a particular strain of COVID-19, such as COVID-19A or COVID-19B. But there is also a lot of evidence to suggest that COVID-19 is related to other types of dementia, like Dementia with Lewy Bodies. Most scientists have focused on developing COVID-19 treatments for Alzheimer’s, but Dementia with Lewy Bodies may be a much bigger threat than Alzheimer’s.
COVID-19 has also been shown to be linked with cardiovascular disease, lung disease, arthritis, cancer, multiple sclerosis, autism, and Parkinson’s disease. It’s been demonstrated that COVID-19 can cause problems with Alzheimer’s disease, but there isn’t enough data to prove that Alzheimer’s caused COVID-19, or vice versa.
A research study on Alzheimer’s patients that investigated the role of COVID-19 in Alzheimer’s disease may have discovered some links between the two diseases. COVID-19 causes damage to the nervous system, leading to immune-related damage and inflammation in the brain. This leads to Alzheimer’s disease-related vascular dysfunction and immune system dysfunction. However, Alzheimer’s may not always lead to vascular disease. Alzheimer’s may only cause certain types of vascular disease, which would not affect COVID-19.
Even though COVID-19 causes a lot of problems in Alzheimer’s patients, it might be beneficial in the fight against Alzheimer’s disease, which is why researchers are looking into COVID-19 treatments. Some studies have found no link between Alzheimer’s and COVID-19, but other studies show a link between Alzheimer’s and COVID-19.
COVID-19 is also a genetically related strain of CVID-19, and researchers have found that COVID-19B and COVID-19C are genetically related to COVID-19A. The COVID-19 strains that cause Alzheimer’s disease differ from the strains that cause Alzheimer’s disease, and it’s believed that Alzheimer’s is caused by COVID-19B and COVID-19C. There is also some evidence suggesting that COVID-19A and COVID-19C are genetically linked to Alzheimer’s disease, and might be responsible for certain strains of Alzheimer’s.
Researchers in one of the early studies of Alzheimer’s patients concluded that Alzheimer’s was related to COVID-19B and COVID-19C, but Alzheimer’s is believed to be the result of COVID-19A and COVID-19C. Researchers are currently working on finding out which COVID-19 strains are responsible for the different types of Alzheimer’s, and hopefully finding a cure.
A COVID-19 treatment that may be more effective than traditional treatments. COVID-19A and COVID-19B can cause inflammation in the brain, which may lead to Alzheimer’s disease, but COVID-19C can decrease inflammation in the brain, which could potentially decrease Alzheimer’s disease. COVID-19A causes inflammation in the brain, while COVID-19B can also cause inflammation in the brain, but COVID-19C can decrease inflammation in the brain. COVID-19B and COVID-19C have also been shown to increase tissue regeneration and improve blood flow in the brain.
